New Directions Technology Consulting, LLC:
Who: | Napoleon Monroe, managing director, New Directions Technology Consulting (New Directions), the inventor of five U.S. patents with granted medication telemanagement claims. New Directions is the exclusive market developer of these patents, included in the mMed patent portfolio. | |||
What/ When: | The Drug Delivery Partnerships 2017 conference, Feb. 7-9, 2017 | |||
Monroe will make two presentations: | ||||
A. February 7, 2:15pm-2:30pm | ||||
Track A presentation: “The Roles of Connected Combination Products in the Creative Reconstruction of Pharma” will: | ||||
• Highlight how connected products can assist in building product and corporate value | ||||
• Address some of the issues that have delayed progress | ||||
• Discuss some latest developments | ||||
B. February 8, 2:15pm-5:00pm | ||||
Track 3 intro and panel moderation: Smart & Novel Drug Delivery Technology | ||||
Where: | PGA National Resort & Spa | |||
400 Avenue of the Champions | ||||
Palm Beach Gardens, FL 33418 | ||||
Why: | The point of care for drug treatment is wherever the patient doses. Improving medication adherence/compliance can improve outcomes and help to reduce the cost of healthcare. Medication telemanagement and formulation innovation also can provide great business opportunities for healthcare stakeholder partnerships, particularly at a time when stakeholders are being asked to demonstrate evidence-based outcomes and improve quality of life. With mobility being crucial to quality of life, there is a strong rationale for a Pharma emphasis on medication telemanagement. Service beyond the script is now an important part of strategies to gain and retain patients/customers. | |||
Contacts: | New Directions media contact: Rick Sacks, rick@smartpr.net, +1 973 467 8728 | |||
Conference contact: Paige Santillo, paige.santillo@knect365.com, +1 646 895 7484 | ||||
Note: mMed is a trademark of New Directions Technology Consulting, LLC. | ||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20170124005484/en/